Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ProCure
- Development stage
- Phase 1
- Lead developer
- Kosmos
- Administration
- Oral
01
Overview
**ProCure** is a proprietary herbal pharmaceutical formula acquired by Cosmos Holdings for development in prostate-health indications, including benign prostate enlargement, prostate infections, prostate cancer, and other urinary problems. Its constituent herbs, active chemical composition, dosage form, route of administration, and molecular mechanism of action have not been publicly disclosed. The acquisition agreement contemplated progression through preclinical, Phase I, Phase II, and Phase III development milestones; no completed clinical development or regulatory approval for the Cosmos product was identified.
- Brand names
- ProCure
Beyond the preview
Go deeper on ProCure.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ProCure.